肠道微生物组的变化受喘控制和治疗水平的影响
Ewelina Harcęko-Zielińska1, Aleksandra Górska1, Jan Romantowski1
1Department of Allergology, Medical University of Gdańsk, Gdańsk, Poland.
Journal of asthma and allergy
|December 29, 2025
概括
喘患者表现出肠道微生物群多样性的减少和较低水平的有益细菌,如菌. 这些变化与喘的严重程度和治疗有关,突出显示了肠道微生物群.
科学领域:
- 微生物组研究的研究.
- 过敏性疾病的发病因子
- 人的肠道微生物群.
背景情况:
- 肠道微生物在过敏疾病的发展中发挥着作用.
- 对喘患者肠道微生物组的研究是有限的.
- 对影响喘微生物群的因素的研究很少.
研究的目的:
- 分析喘患者与对照患者的肠道微生物群组成,饮食习惯和BMI.
- 在喘患者和健康个体之间比较这些参数.
- 研究肠道微生物群对喘治疗结果的影响.
主要方法:
- 收集了49名喘患者和18名健康志愿者的便样本.
- 测序细菌16S rRNA以确定肠道微生物群的组成.
- 采用问卷收集临床数据和饮食信息.
主要成果:
- 喘患者在肠道微生物群中显示出明显较低的α和β多样性.
- 在喘患者中观察到Faecalibacterium的丰度减少.
- 在不受控制的喘中观察到特定的微生物枯竭 (Oscilospirales,Anaerovoracaceae);使用葡萄糖皮质体改变了微生物群组成.
结论:
- 与健康个体相比,喘患者的肠道微生物群的多样性较小.
- 肠道微生物组的改变与喘的严重程度和治疗有关.
- 需要进一步的研究来理解因果关系.
更多相关视频
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
13.8K
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
10.2K
相关概念视频
Anatomy of the Intestines
86.5K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.5K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Asthma-II: Pathophysiology and Classification
4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
